[Business Wire] – Medgenics, Inc. , the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that, in connection with its previously announced publi moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, […]
moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, click here to view […]
moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, click here to view […]
[ACN Newswire] – Medgenics’ (NYSEAMEX: MDGN) INFRADURE(TM) provides sustained production and delivery of interferon-alpha for the treatment of hepatitis. INFRADURE(TM) is a kind of miniature pump that is impacted into … moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, click here to view […]
[Business Wire] – MISGAV, Israel & SAN FRANCISCO–(BUSINESSWIRE)– Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Companyâ€), the developer of a novel technology for the sustained production and delivery of therapeutic … moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, click here to view […]
